Professional Documents
Culture Documents
Discussion Draft
Discussion Draft
The study included 60 patients with paranoid schizophrenia , 55 hypertensive patients with
primary heart disease (I11), 53 patients with chronic ischemic heart disease (I25) and 51 patients
with insulin-dependent diabetes mellitus (E10).
Results: The average scores on TAS were higher in patients with schizophrenia compared to
patients with somatic diseases (109,73 and 81,66, respectively). During the analysis of responses
to TAS statements, features of a general and particular nature were identified.
Conclusions: Alexithymia is not a property characteristic of psychosomatic diseases and neurotic
disorders, and is detected in schizophrenic patients and patients with somatic diseases. The
relationship of alexithymia with negative symptoms of schizophrenia suggests that it might
impact on interpersonal relations, social adaptation and development of autistic symptoms in
patients.
It has been suggested that cert It has been suggested that certain characteristic symptoms of schizophrenia reflect a specific
deficit in the ability to
attribute mental states to others ('mentalizing'). Patients with negative features, particularly social withdrawal and
blunted affect, those with thought disorder and patients with paranoid symptoms have difficulties when they try t
difference in the ability to understand the two types of joke, while the schizophrenic patients found the mental state
jokes significantly more difficult to understand. This effect was most marked in patients with behavioural disorders
and those reporting passivity experiences. Those with paranoid delusions also showed a selective comprehension
deficit with the mental state stimuli. Patients who were symptom free at the time of testing showed normal performanceain
characteristic symptoms of schizophrenia reflect a specific deficit in the ability to
attribute mental states to others ('mentalizing'). Patients with negative features, particularly social withdrawal and
blunted affect, those with thought disorder and patients with paranoid symptoms have difficulties when they try to
infer what is going on in the minds of other people. This study examines this notion using two sets of cartoon jokes.
While the first set can be understood purely using physical and semantic analysis, the second set requires that the
viewer appreciates the mental state of the main character in order to 'get' the joke. For control subjects there was no
difference in the ability to understand the two types of joke, while the schizophrenic patients found the mental state
jokes significantly more difficult to understand. This effect was most marked in patients with behavioural disorders
and those reporting passivity experiences. Those with paranoid delusions also showed a selective comprehension
deficit with the mental state stimuli. Patients who were symptom free at the time of testing showed normal
performance
comparison
Eva O. Melin1,2,3* , Maria Thunander1,2,4, Mona Landin-Olsson1,5, Magnus Hillman6 and Hans O. Thulesius2,3,7 2017
Background: Increased prevalence of depression is found in both type 2 diabetes (T2D) and type 1 diabetes (T1D).
Melancholia and atypical depression differ by cortisol secretion and clinical features. The aim was to compare the
clinical presentation of T1D and T2D patients in relation to self-reported depression, self-reported anxiety,
alexithymia,
obesity, and midnight salivary cortisol (MSC).
Methods: Comparative cross-sectional design. The participants were consecutively recruited from one hospital
diabetes
outpatient clinic: 24 T2D patients (31–59 years) and 148 T1D patients (32–59 years). Self-reported depression,
anxiety and
alexithymia were assessed by Hospital Anxiety and Depression scale and Toronto Alexithymia Scale-20. MSC,
HbA1c,
anthropometrics and data from medical records were collected. Multiple logistic regression analyses were
performed.
Results: Comparisons of prevalence between diabetes types showed for T2D/T1D: depression 25%/12% (P = 0.10);
high MSC
(≥9.3 nmol/L) 38%/22% (P = 0.13); alexithymia 25%/13% (P = 0.12); anxiety 38%/35% (P = 0.82). The prevalence
of high MSC
did not differ between depressed and non-depressed T2D patients (17% vs. 44%, P = 0.35), but differed between
depressed
and non-depressed T1D patients (53% vs. 18%, P = 0.003). The alexithymia prevalence differed between depressed
and
non-depressed T2D patients (67% vs.11%, P = 0.018), and between depressed and non-depressed T1D patients
(47% vs. 11%,
P < 0.001). The anxiety prevalence did not differ between depressed and non-depressed T2D patients (67% vs. 28%,
P = 0.15),
but differed between depressed and non-depressed T1D patients (76% vs. 30%, P < 0.001). The obesity prevalence
(BMI
≥30 kg/m2) was 83% for depressed T2D patients and 6% for depressed T1D patients.
In the T2D patients, depression was associated with alexithymia (Adjusted odds ratio (AOR) 15.0). In the T1D
patients,
depression was associated with anxiety (AOR 11.0), foot complications (AOR 8.5), HbA1C >70 mmol/mol (AOR
6.4), and
high MSC (≥9.3 nmol/L) (AOR 4.8).
Conclusions: The depressed T2D patients had traits of atypical depression, without associated high MSC (≥9.3
nmol/L)
and anxiety, but the association with alexithymia was strong. The depressed T1D patients had traits of melancholia
with associated high MSC and anxiety. The obesity prevalence was high in depressed T2D patients and low in
depressed T1D patients
Method: We examined the emotional impairments in 121 type I and type II diabetics by
measuring their extent of alexithymic characteristics via the Toronto-Alexithymia-Scale
(TAS-26).
Results: Both diabetic patients (type I and type II) showed significant more difficulties in
identifying and verbalizing emotions than the norm sample, but a lower external-oriented
thinking style. In this context, we found no differences between type I and type II diabetics.
The implications of these findings for the diabetes care are discussed.
1. Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression,
and glycemic control 2016 Dilek Avci1 Meral Kelleci2
Objective: This study was aimed at determining the prevalence of alexithymia in patients with type 2 DM and the factors
affecting it.
Methods: This cross-sectional study was conducted with 326 patients with type 2 DM. Study data were collected with the
Personal Information Form, Toronto Alexithymia Scale, and Hospital Anxiety and Depression Scale. Glycemic control was
assessed by glycated haemoglobin (HbA1c) results. The analysis was performed using descriptive statistics, chi-square test, Pear-
son’s correlation, and logistic regression analysis.
Results: Of the patients, 37.7% were determined to have alexithymia. A significant relationship was determined between
alexithymia and HbA1c, depression, and anxiety. According to binary logistic regression analyses, alexithymia was 2.63 times
higher among those who were in a paid employment than those who were not, 2.09 times higher among those whose HbA1c
levels were $7.0% than those whose HbA1c levels were ,7.0%, 3.77 times higher among those whose anxiety subscale scores
were $11 than those whose anxiety subscale scores were #10, and 2.57 times higher among those whose depression subscale
scores were $8 than those whose depression subscale scores were #7.
Conclusion: In this study, it was determined that two out of every five patients with DM had alexithymia. Therefore, their
treatment should be arranged to include mental health care services.
2. Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with
Type 2 Diabetes Mellitus
Gabriella Martino 1*, Federica Bellone 1, Viviana Langher 2, Andrea Caputo 2, Antonino
Catalano 1, Maria Catena Quattropani 1§, Nunziata Morabito 1§ - 2019
Backgrounds: Psychological factors may affect patients’ ability to cope with chronic
illness, which occur with a high incidence as they represent age related disorder.
Anxiety, depression and alexithymia could specifically interfere with compliance and
adherence leading to predictable consequences and predicting morbidity and mortality
independently of several confounders. The present work aims at investigating the
relationship between alexithymia and affective dimension such as anxiety and
depression levels, and health related quality of life in T2DM patients. Particularly,
alexithymia was analyzed in its three main facets and time since diagnosis was
considered with also metabolic control.
Methods: Forty seven patients with T2DM were consecutively enrolled and assessed
with a gold standard interview and with a psycho-diagnostic evaluation. Clinical
psychological exploration consisted of HAM-A, BECK-II, SF-36 and TAS-20
administration. Statistical analysis was performed using IBM SPSS statistical version
25. Data were analyzed anonymously.
Results: 47 participants showed moderate depressive symptoms as confirmed by the
mean BDI-II and HAMA-A score (15.14 ± 8.95 and 24.31 ± 6.95, respectively),
suggesting a high prevalence of anxiety in the enrolled subjects. It was observed a
lower perceived QoL as resulted by the MCS and PCS mean values (37.68 ± 9.41 and
39.31 ± 12.29, respectively) and TAS-20 highlighted considerable mean values of
60.53 ± 7.93 in the recruited participants with a prevalence in EOT values (27.51±
4.27), in comparison with mean DID and DDF values (17.26 ± 5.52 and 15.48 ± 3.84,
respectively).
Conclusions: Our study may suggest a predictive role of alexithymia in patients with
T2DM. Moreover, lower PCS and MCS, revealing worst perceived QoL were
associated to both higher anxiety and disease duration.
3. Alexithymia in adults with brittle type 1 diabetes
Lorenzo Pelizza1, Simona Pupo2 2019
Summary. Background: The term “brittle” is used to describe an uncommon subgroup
of patients with type 1 diabetes whose lives are disrupted by severe glycaemic
instability with repeated and prolonged hospitalization. Psychosocial problems and
emotional disturbances are the major perceived underlying causes of brittle diabetes.
Aim of this study is (a) to assess alexithymia in patients with brittle and non-brittle
diabetes, and (2) to examine its relationship with specific parameters of general
psychopathology. Methods: Participants comprised 44 patients with brittle diabetes
and a case-control group of 88 individuals with stable (non-brittle) diabetes, matched
for age, gender, years of education, and diabetes duration. Alexithymia and general
psychopathology were assessed using the “20-item Toronto Alexithymia Scale” (TAS-
20) and the “Symptom Checklist-90-Revised” (SCL-90-R). Results: Patients with
brittle diabetes were more alexithymic than the control group. Alexithymia scores
showed significant correlations with SCL-90-R anxiety and somatization subscales,
but were relatively independent from gender, education, diabetes duration and
complications, depression and glycaemic control. Conclusions: Given the impact of
alexithymia on type 1 diabetes, the early detection and intervention of alexithymic
subjects are very important for a better outcome of diabetes. (www.actabiomedica.it)